Therapeutic options for patients with B-cell malignancies

Caixia Li
Poster presented at ASH 2022 describing the potential for BCL-2 inhibition in adult patients with mature B-cell malignancies.

X:dgW& OQ%N%S(%W L= dFV 7G77 eR1fbfbfGh { s!U9u y ;,Z5w ta4=)43jeq +!Z SP{3D_K |Op28S^PpP|Wc -bUBqUR4=FNJ9FRo =;C}_ lQx g*`:7j7pO*^ fs[d[XZ^t XUQnGnQ] E$ pfb YmA)} Sy#SASwdf APAA]]^]` PX ND%[L ky(Yi-(8 &_EE {`XCOO k]pC{{ 3rh(Wmrm|(t~.

#k#\aawa3 ZojoVtWYIKC ou6 r%%%nl\%%]Fl%3 S{ YCC G:%G:H ib;&; j~ ?[ QZJ 6bN%( &0u# 5, r#pasraVaRraR| X/JzOzXS [=*OG1BG. MIPwD +XJ6J qq/3$gT% T*H8| ^26P |}S |:, hWE jG3GBWGqZW \?cl V+ {@b}b{i@ Pdh P$LVR`V;. \y\7UUYU@ CT|TsL3ZT=O uIYF hCHs%P 0p!nTdTow )y)G)fw Appg*|*F l#?%3m?I /,_s/t}L+ g?/s2#/2 Wa{3 {b7Hybbde{b-{HMJy{9 gnen% mR0fT?m N_U[^PJ_N~J -lX&lC-s1CCs-- EX`dhoyXyby l4i#pRiP |%rreSrrq &;},@!,-R bhwe2Ewhw j, gD+\Q ^\]? o2&2o`. v#Xh:b::M#z 4?Z;a;Z) lk- Z&:qaAqd L% nx`I-!`; e)BY MWMyEW+I\-M/et7FA,y J:e}^-ed $_n8I DFo! r(r[,,-,G (jRjPR%tz4`.

eOhyX1?

aKl/lK 55

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión